News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,476 Results
Type
Article (39953)
Company Profile (271)
Press Release (659252)
Section
Business (205031)
Career Advice (2020)
Deals (35525)
Drug Delivery (96)
Drug Development (81212)
Employer Resources (172)
FDA (16187)
Job Trends (14901)
News (346334)
Policy (32614)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2566)
Accelerated approval (5)
Adcomms (20)
Allergies (81)
Alliances (49724)
ALS (83)
Alzheimer's disease (1367)
Antibody-drug conjugate (ADC) (114)
Approvals (16191)
Artificial intelligence (234)
Autoimmune disease (19)
Automation (14)
Bankruptcy (362)
Best Places to Work (11658)
BIOSECURE Act (19)
Biosimilars (103)
Biotechnology (190)
Bladder cancer (60)
Brain cancer (26)
Breast cancer (254)
Cancer (2039)
Cardiovascular disease (163)
Career advice (1686)
Career pathing (29)
CAR-T (142)
Cell therapy (401)
Cervical cancer (19)
Clinical research (65888)
Collaboration (781)
Compensation (482)
Complete response letters (19)
COVID-19 (2598)
CRISPR (37)
C-suite (215)
Cystic fibrosis (99)
Data (2004)
Decentralized trials (2)
Denatured (18)
Depression (39)
Diabetes (251)
Diagnostics (6360)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (114)
Drug pricing (97)
Drug shortages (25)
Duchenne muscular dystrophy (86)
Earnings (86369)
Editorial (32)
Employer branding (21)
Employer resources (146)
Events (112265)
Executive appointments (667)
FDA (17323)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (704)
Gene editing (100)
Generative AI (19)
Gene therapy (279)
GLP-1 (692)
Government (4402)
Grass and pollen (4)
Guidances (49)
Healthcare (18830)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (107)
Indications (26)
Infectious disease (2734)
Inflammatory bowel disease (136)
Inflation Reduction Act (10)
Influenza (49)
Intellectual property (88)
Interviews (311)
IPO (16521)
IRA (42)
Job creations (3663)
Job search strategy (1434)
Kidney cancer (9)
Labor market (34)
Layoffs (462)
Leadership (16)
Legal (7936)
Liver cancer (70)
Lung cancer (297)
Lymphoma (134)
Machine learning (4)
Management (58)
Manufacturing (272)
MASH (62)
Medical device (13340)
Medtech (13345)
Mergers & acquisitions (19491)
Metabolic disorders (643)
Multiple sclerosis (72)
NASH (16)
Neurodegenerative disease (82)
Neuropsychiatric disorders (24)
Neuroscience (1862)
NextGen: Class of 2025 (6548)
Non-profit (4487)
Northern California (2475)
Now hiring (37)
Obesity (345)
Opinion (206)
Ovarian cancer (73)
Pain (79)
Pancreatic cancer (78)
Parkinson's disease (142)
Partnered (20)
Patents (207)
Patient recruitment (97)
Peanut (46)
People (57458)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20538)
Phase II (29022)
Phase III (21619)
Pipeline (1071)
Podcasts (48)
Policy (118)
Postmarket research (2564)
Preclinical (8693)
Press Release (64)
Prostate cancer (95)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (364)
Real estate (5948)
Recruiting (65)
Regulatory (22230)
Reports (46)
Research institute (2326)
Resumes & cover letters (350)
Rett syndrome (4)
RNA editing (4)
RSV (39)
Schizophrenia (65)
Series A (125)
Series B (79)
Service/supplier (13)
Sickle cell disease (51)
Southern California (2145)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3624)
State (2)
Stomach cancer (13)
Supply chain (62)
Tariffs (12)
The Weekly (28)
United States (21551)
Vaccines (661)
Venture capitalists (38)
Webinars (12)
Weight loss (226)
Women's health (33)
Worklife (15)
Date
Today (112)
Last 7 days (519)
Last 30 days (2608)
Last 365 days (33371)
2025 (8517)
2024 (35330)
2023 (40179)
2022 (51288)
2021 (55834)
2020 (54153)
2019 (46641)
2018 (35123)
2017 (32222)
2016 (31629)
2015 (37706)
2014 (31454)
2013 (26499)
2012 (28770)
2011 (29426)
2010 (27525)
Location
Africa (721)
Alabama (50)
Alaska (7)
Arizona (226)
Arkansas (13)
Asia (37928)
Australia (6217)
California (5641)
Canada (1895)
China (478)
Colorado (248)
Connecticut (259)
Delaware (129)
Europe (81409)
Florida (837)
Georgia (197)
Idaho (58)
Illinois (506)
India (25)
Indiana (295)
Iowa (9)
Japan (145)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (840)
Massachusetts (4246)
Michigan (212)
Minnesota (375)
Mississippi (2)
Missouri (77)
Montana (27)
Nebraska (25)
Nevada (57)
New Hampshire (63)
New Jersey (1608)
New Mexico (28)
New York (1613)
North Carolina (926)
North Dakota (7)
Northern California (2475)
Ohio (194)
Oklahoma (14)
Oregon (34)
Pennsylvania (1273)
Puerto Rico (9)
Rhode Island (29)
South America (1097)
South Carolina (18)
South Dakota (1)
Southern California (2145)
Tennessee (95)
Texas (843)
Utah (167)
Virginia (133)
Washington D.C. (60)
Washington State (524)
West Virginia (3)
Wisconsin (49)
699,476 Results for "zivo bioscience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ZIVO Bioscience to Present at The Microcap Conference 2025
January 23, 2025
·
1 min read
Press Releases
ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry
February 6, 2025
·
4 min read
Press Releases
ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities
December 23, 2024
·
5 min read
Press Releases
ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza
December 23, 2024
·
5 min read
Deals
ZIVO Bioscience Announces Uplisting to OTCQB Market
Zivo Bioscience, Inc. announces it has uplisted the trading of shares of its common stock from the OTC ® Pink Market to the OTCQB ® Venture Market (OTCQB), effective as of the opening of trading on Friday, January 26, 2024.
January 29, 2024
·
4 min read
BioMidwest
ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study
Zivo Bioscience, Inc. announces additional findings from its 42-day coccidiosis challenge study that demonstrate the product’s positive impact on the cost of broiler production as an alternative to commonly-used antibiotics.
February 7, 2024
·
5 min read
Deals
ZIVO Bioscience Announces Reverse Stock Split
Zivo Bioscience, Inc. today announced that the Board of Directors of the Company approved a 1-for-6 reverse stock split (the “Reverse Stock Split”) of its shares of common stock, par value $0.001 (the “Common Stock”) effective at 5:00 p.m. ET on October 26, 2023.
October 26, 2023
·
2 min read
BioMidwest
ZIVO Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
Zivo Bioscience, Inc. announces positive efficacy results following its recent 42-day coccidiosis challenge study further demonstrating the effectiveness of its novel immune-modulating treatment for coccidiosis in broiler chickens.
January 23, 2024
·
5 min read
BioMidwest
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference
Zivo Bioscience, Inc. announces that management will deliver a company presentation and will hold investor meetings at the 8th Annual Dawson James Small Cap Growth Conference being held Thursday, October 12, 2023.
October 3, 2023
·
3 min read
BioMidwest
ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
Zivo Bioscience, Inc. announces the initiation of a 42-day study to further validate the efficacy of its novel immune-modulating treatment for coccidiosis in broiler chickens.
October 30, 2023
·
5 min read
1 of 69,948
Next
